Image For Activity Cover
2021 ACMG Annual Clinical Genetics Meeting Digital Edition
 
First time Users

First time users: You will need to check your degree as you created an ACMG account. The system designates educational credits according to your degree. Be sure you are logged in (do you see your name on the top right under the ACMG Genetics Academy logo?). If not, log in before proceeding.

For technical support, please send an email to: education@acmg.net  or call 301-718-9603.

Or click on the "Help" icon on the left-hand side of your screen for more information.
Support Center Hours: Monday- Friday 9:00 am - 5:00 pm Eastern Time 

Course Information

Date of Release: July 19, 2021

Expiration Date: July 1, 2023

Credits offered: CME, P.A.C.E.®, NSGC

Estimate time of completion: 62 hours

Course must be completed by the expiration date and NSGC credits are reported one time.

www.acmgeducation.net

 

Course Description

The 2021 ACMG Annual Clinical Genetics Meeting Digital Edition presents both research and clinical topics that promote the science and the practice of clinical genetics and genomics. Sessions focus on the latest discoveries of the etiology and the pathogenesis of genetic disorders, the latest developments in genetic testing and screening, the laboratory’s role in the diagnosis of genetic disorders, the treatment of genetic disorders in children and adults, the delivery of genetic services, and more.

This course contains accredited sessions with recorded content and live Q&A, ondemand sessions, scientific sessions, and platform sessions.

Target Audience

All healthcare professionals interested in the diagnosis, management, treatment and prevention of genetic conditions and increasing their understanding of the genetic basis of common, chronic health problems affecting both children and adults will find the programming applicable to their practice. These select sessions from the ACMG Annual Meeting are targeted for the following professionals:

  • Medical and clinical geneticists; genetic counselors; pediatric, obstetric, and maternal-fetal specialists; and all medical practitioners who are providing comprehensive diagnostic, management, and counseling services for patients with, or at risk for, genetically influenced health problems
  • Laboratory directors and technicians who conduct genetic testing
  • Researchers involved in the discovery of genetic disorders and treatments
  • Clinical, laboratory and research trainees of genetics and all biomedical sciences
  • Any healthcare and public health professionals who have an in interest in medical and clinical genetics and genomics
  • Advocates for patients with genetic conditions and their families

Learning Objectives

At the conclusion of this session, participants should be able to:

  • Describe the advances in genetic testing including prenatal and postnatal indications, gene panels, genome sequencing, interpretation, genetic counseling, and ethical and legal issues.
  • Review select rare and common genetic disorders, from developmental disabilities to cancer predisposition syndromes, and learn about novel therapeutic approaches including gene editing.
  • Review select inborn errors of metabolism, approaches to their diagnoses and treatment, as well as new disorders on the recommended uniform screening panel.
  • Discuss challenges of the COVID 19 pandemic and different solutions to deliver the tripartite mission of clinical care, education, and research in medical genetics.
  • Describe a potpourri of issues relating to medical genetics including history; ethical, legal and regulatory issues; health disparities, job negotiation; and many others.

Continuing Education Information

CME, P.A.C.E®., NSGC Educational Credits 

Continuing Medical Education (CME)
Accreditation
The American College of Medical Genetics is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
The American College of Medical Genetics and Genomics designates this enduring activity for a maximum of 62 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Medical Association (AMA) defines physicians as those individuals who have obtained an MD, DO, or equivalent medical degree from another country.
Non-physicians may request a certificate of attendance for their participation.

Genetic Counselor Credit

NSGC CEUs - The National Society of Genetic Counselors (NSGC) has authorized ACMG to offer up to 6.02 CEUs or 62.0 Category 1 contact hours for the activity 2021 ACMG Annual Clinical Genetics Meeting – Digital Edition. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification.

ACMG will report completed accredited sessions to NSGC for credit certificates on December 3, 2021, and December 8, 2022, and July 3, 2023. Submissions outside of these parameters may incur a processing fee of $35. All course work must be reported one time as a total and not cumulated. Please watch for email from ACMG for verification of reporting.

P.A.C.E.® CEU's 
ACMG is approved as a provider of continuing education programs in the clinical laboratory sciences by the American Society for Clinical Laboratory Science (ASCLS) Professional Acknowledgment for Continuing Education (P.A.C.E.®) Program.

ACMG is approved by the Florida Board of Clinical Laboratory Personnel as CE Provider (50-11878). This course is registered with CEBroker #
20-865016. ACMG is approved by the California Department of Health Services through the ASCLS P.A.C.E.®. This activity has been approved for 62 P.A.C.E.® CEU's.

Participation Instructions (OnDemand)

  1. Complete session by watching recordings.
  2. Pass a post-test with a score of 80% or better (Learning mode activated and reset).
  3. Complete session evaluations.

Disclosure Statement

It is the policy of the American College of Medical Genetics and Genomics to plan and implement all of its educational activities in accordance with the ACCME Essentials and Areas and ACCME® Policies to ensure balance, independence, objectivity and scientific rigor. In accordance with the ACCME® Standards for Commercial Support, everyone (speakers, moderators, committee members and staff) who is in a position to control the content of an educational activity certified for AMA PRA Category 1 Credit™ is required to disclose all financial relationships with any commercial interests within the past 12 months that creates a real or apparent conflict of interest. Individuals who do not disclose will be disqualified from participating in a CME activity.

This disclosure pertains to relationships with ACCME-defined commercial interests whose products or services may be related to the subject matter of the presentation topic. Any real or apparent conflicts of interest related to the content of the presentations must be managed prior to the educational activity. ACMG will identify, review and resolve all conflicts of interests prior to an educational activity being delivered to learners.

NOTE:

  • ACMG will follow the ACCME’s expectation that no employees or owners of commercial interests will be involved as planners/faculty/presenters of a CME accredited activity.
  • The ACCME definition of a commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
  • The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical service is owned, or controlled by, an ACCME-defined commercial interest.
  • Diagnostic laboratories are not considered commercial interests unless they are owned by or have a sister organization which is a commercial interest.

Content Validation and Fair Balance

  1. ACMG follows the ACCME policy on Content Validation for CME activities, which requires:
  2. a) All recommendations involving clinical medicine must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients.
  3. b) All scientific research referred to, reported or used in CME in support or justification of patient care recommendations must conform to the generally accepted standards of experimental design, data collection and analysis.
  4. Activities that fall outside the definition of CME/CE; “Educational activities that serve to maintain, develop, or increase the knowledge, skills, and professional performance and relationships that a physician uses to provide services for patients, the public, or the profession” (source: ACCME and AMA) will not be certified for credit. CME activities that promote recommendations, treatment, or manners of practicing medicine or pharmacy that are not within the definition of CME/CE or, are known to have risks or dangers that outweigh the benefits or, are known to be ineffective in the treatment of patients.
  5. Presentations and CME/CE activity materials must give a balanced view of therapeutic options; use of generic names will contribute to this impartiality. If the CME/CE educational materials or content includes trade names, where available, trade names from several companies must be used.

Off-Label Uses of Products

When an off-label use of a product, or an investigational use not yet approved for any purpose, is discussed during an educational activity, the accredited sponsor shall require the speaker to disclose that the product is not labeled for the use under discussion, or that the product is still investigational. Discussions of such uses shall focus on those uses that have been subject of objective investigation.

HIPAA Compliance by Faculty

The ACMG supports medical information privacy. While the ACMG is not a “covered entity” under HIPAA 1996 and therefore is not required to meet these standards, ACMG wishes to take reasonable steps to ensure that the presentation of individually identifiable health information at ACMG-sponsored events has been properly authorized. All presenters have completed a form indicating whether they intend to present any form of individually identifiable healthcare information. If so, they were asked either to at that a HIPAA-compliant consent form is on file at their institution, or to send ACMG a copy of the HIPAA compliance form. This information is on record at the ACMG Administrative Office and will be made available upon request.

Disclaimer

ACMG educational programs are designed primarily as an educational tool for health care providers who wish to increase their understanding of the application of genomic technologies to patient care. The ACMG does not endorse or recommend the use of this educational program to make patient diagnoses, particular by individuals not trained in medical genetics. Adherence to the information provided in these programs does not necessarily ensure a successful diagnostic outcome. The program should not be considered inclusive of all proper procedures and s or exclusive of other procedures and s that are reasonably directed at obtaining the same results. In determining the propriety of any specific procedure or, a healthcare provider should apply his or her own professional judgment to the specific clinical circumstances presented by the individual patient or specimen.

Questions regarding CE credit should be directed to education@acmg.net

Financial Disclosures

The following reported disclosures and none are relevant to the content of this course. All of the relevant financial relationships listed for these individuals have been mitigated.

 

Jennelle C. Hodge, PhD, FACMG (Co-Chair)

Program Committee

Nothing to disclose

 

 

 

Tuya Pal, MD, FACMG (Co-Chair)

Program Committee

Nothing to disclose

Myra Wick, MD, PhD, FACMG (Vice Chair)

Program Committee

Nothing to disclose

Anthony Gregg, MD, MBA, FACOG, FACMG (President)

Program Committee

Nothing to disclose

Kristina Cusmano-Ozog, MD, FACMG

Program Committee

Nothing to disclose

Keith Eddleman, MD, FACMG

Program Committee

Nothing to disclose

Michael Gambello, MD, FACMG

Program Committee

Nothing to disclose

Gerard Berry, MD, FACMG (SIMD Liaison)

Program Committee

Nothing to disclose

Jodi D. Hoffman, MD, FACMG

Program Committee

Nothing to disclose

Jennifer King, MD, MS (Candidate Fellow)

Program Committee

Nothing to disclose

Kelsey McIntyre, PhD, FACMG

Program Committee

Nothing to disclose

Wendy Rubinstein, MD, FACMG

Program Committee

Nothing to disclose

Anne Slavotinek, PhD, FACMG (Education Committee Liaison)

Program Committee

Nothing to disclose

Jessica Smith, MD, FACMG

Program Committee

Nothing to disclose

Eli Williams, PhD, FACMG

Program Committee

Nothing to disclose

Samantha Stover, MS, CGC

Program Committee

Nothing to disclose

Max Muenke, MD, FACMG (Chief Executive Officer)

Program Committee

Nothing to disclose

Jane Dahlroth, CEM, CMP-HC (Senior Director Meetings & Exhibits)

Program Committee

Nothing to disclose

Jane Radford, MHA, CHCP (Director of Education)

Program Committee

Nothing to disclose

Penelope Freire, CMP (Associate Director, Meetings & Exhibits)

Program Committee

Nothing to disclose

Claudia Barnett (Senior Education Program Coordinator)

Program Committee

Nothing to disclose

Jenna Cohen, CMP (Manager, Meetings & Exhibits)

Program Committee

Nothing to disclose

Sarah Elsea, PhD, FACMG

Program Committee

Research Grants with NIH, PRISMS, Inc., Shire Genetic Therapies, Rhythm Therapeutics, Jerome Lejeune Foundation; Consultant with Enzyvant and Speragen, Member of ACMG Foundation Board

Akash Kumar, MD, PhD (Trainee)

Program Committee

Major Stockholder in MyOme, Inc.

David Stevenson, MD, FACMG

Program Committee

Research Grant with Soleno clinical trial, Consultant with GLG and BMJ Publisher, Member of Costello support group, CFC support group, and PWSA Support Group


 

Speakers and Moderators Disclosures

Presenters and moderators have disclosed the following:
[Last name, First Name, Degree(s)]

Name

Role(s)

Disclosure

Abul-Husn, Noura,MD, PhD, MS, FACMG

Presenter

Previously employed relationship with Regeneron Pharmaceuticals; Speaker/Speaker's Bureau relationship with Genentech

Adashi, Eli,MD, MS

Presenter

Consultant relationship with Ohana Biosciences

Ammous, Zeinab, MD

Presenter

Consultant relationship with Travere Therapeutics; Consultant relationship with CoA Therapeutics

Berry, Susan, MD

Presenter

DSMB Member relationship with Sanofi; Clinical Trial Site PI relationship with Hemoshear; Clinical Trial Site PI relationship with Arturus

Biffi, Alessandra, MD

Presenter

reserach funding relationship with Altheia Science

reserach funding, patent and royalties relationship with Orchard Therapeutics

Brigatti, Karlla, MS

Presenter

Advisory Committee Member relationship with Novartis Gene Therapies

Burghes, Arthur, PhD

Presenter

Consultant relationship with Norvartis Gene Therapy

Cherqui, Stephanie, PhD

Presenter

Owner/Founder relationship with Stelios Therapeutics Inc; Consultant relationship with AVROBIO

Chung, Wendy,MD, PhD

Presenter

Scientific Medical Advisor relationship with Regeneron Genetic Center

Speaker/Speaker's Bureau relationship with Rhythm

Cunniff, Christopher, MD

Presenter

Consultant relationship with Sterigenics; Advisory Committee Member relationship with Biogen; Advisory Committee Member relationship with Amgen

Daly, Mark, PhD

Presenter

Owner/Founder relationship with MAZE Therapeutics

Dhar, Shweta, MD

Presenter

Owner/Founder relationship with PanGenomics India

 

Dimmock, David, MD

Presenter

Advisory Committee Member relationship with Audentes

Advisory Committee Member relationship with Biomarin

Advisory Committee Member relationship with Complete Genomics

Flannery, David, MD

Presenter

Stockholder relationship with Salus Telehealth

Francomano, Clair, MD

Presenter

Consultant relationship with Acer Therapeutics

Scientific Medical Advisor relationship with Kyani International

Gillingham, Melanie, PhD

Presenter

Patents/Royalties relationship with Ultragenyx; Consultant relationship with Reneo; Speaker/Speaker's Bureau relationship with Vitaflo; Speaker/Speaker's Bureau relationship with Rockpointe CME; Speaker/Speaker's Bureau relationship with Total CME

Gregg, Anthony, MD, MBA, FACOG, FACMG

Presenter

Consultant relationship with I do participate in medical legal consulting - defense

 

Hajirasouliha, Iman, PhD

Presenter

Owner/Founder relationship with STORK AI

Hakim, Alan, MB MA

Presenter

Consultant relationship with The Ehlers-Danlos Society

 

Harding, Cary, MD

Presenter

Scientific Medical Advisor relationship with BioMarin Pharmaceutical Corp.; Research Funding relationship with Ultragenyx Pharmaceutical; Scientific Medical Advisor relationship with Sanofi/Genzyme; Scientific Medical Advisor relationship with Synlogic, Inc.

 

Haywood, Trent, MD

Presenter

Founder, Knowality LLC

Hirschhorn, Joel, MD/PhD

Presenter

Advisory Committee Member relationship with Camp4 Therapeutics

Kamihara, Junne, MD, PhD

Presenter

Research Funding relationship with ACD-Biotechne

Consultant relationship with EMD Millipore Sigma

Consultant relationship with Foundation Medicine, Inc.

Speaker/Speaker's Bureau relationship with NanoString Technologies

Owner/Founder relationship with PanTher Therapeutics

Consultant relationship with Pfizer

Research Funding relationship with PureTech

Research Funding relationship with Ribon Therapeutics

Owner/Founder relationship with Rome therapeutics

Consultant relationship with Rome Therapeutics

Owner/Founder relationship with TellBio, Inc.

Consultant relationship with Third Rock Ventures

Karaa, Amel, MD

Presenter

Research Funding relationship with Idorsia

Research Funding relationship with Impeto

Research Funding relationship with Protalix

Research Funding relationship with Sanofi Genzyme

Consultant relationship with Stealth biotherapeutics

Research Funding relationship with Takeda

Kuhn, Robert, PhD

Presenter

Patents/Royalties relationship with UCSC Genome Browser authors

Lianoglou, Billie, LCGC

Presenter

Employee relationship with Denali Therapeutics

Lin, Angela, MD, FACMG

Presenter

Consultant relationship with Massachusetts Department Public Health

 

Luedecke, Amanda, MS

Presenter

Consultant relationship with MyGeneCounsel

Martin, Kimberly, MD

Presenter

Consultant relationship with Natera

McBride, Kim, MD

Presenter

Research Funding relationship with Biomarin; Research Funding relationship with Abeona; Research Funding relationship with Homology

Murray, Michael, MD

Presenter

Scientific Medical Advisor relationship with 54gene

Parikh, Sumit, MD

Presenter

Employee relationship with Cleveland Clinic; Scientific Medical Advisor relationship with CHAMP Foundation; Research Funding relationship with Astellas; Scientific Medical Advisor relationship with UMDF; Research Funding relationship with Acadia; Research Funding relationship with Minovia

Pratt, Victoria, PhD

Presenter

Advisory Committee Member relationship with Avalon Healthcare, LLC

Robinson, Peter, MD, PhD

Presenter

Patents/Royalties relationship with The Jackson Laboratory

Scott, Stuart, PhD

Presenter

Consultant relationship with Sema4

 

Simpson, Joe Leigh, MD

Presenter

Advisory Committee Member relationship with Illumina

Steiner, Robert, MD

Presenter

Employee relationship with PreventionGenetics; stock and consultant relationship with Acer Therapeutics

 

Stewart, Douglas, MD

Presenter

Consultant relationship with Genome Medical, Inc

 

Sutton, V. Reid, MD

Presenter

Laboratory Director, Salary Support relationship with Baylor Genetics

 

Van den Veyver, Ignatia, MD, FACMG

Presenter

Reagents to support NIH-funded project relationship with Illumina, SAB member, no financial compensation relationship with Baylor Genetics

 

Venditti, Charles, MD/PhD

Presenter

Research Funding relationship with Moderna; Research Funding relationship with LogicBio; Research Funding relationship with AskBio; Research Funding relationship with Translate Bio

Vora, Neeta, MD, FACMG

Presenter

Research Funding relationship with Illumina

 

Wasserstein, Melissa, MD

Presenter

Consultant relationship with Sanofi Genzyme; Consultant relationship with Sanofi Genzyme; Research Funding relationship with Sanofi-Genzyme; Consultant relationship with Takeda; Research Funding relationship with Ara Parseghian Medical Research Fund; Research Funding relationship with BioMarin; Research Funding relationship with Cure Sanfilippo Foundation; Research Funding relationship with Dana's Angels Research Trust; Research Funding relationship with Firefly Fund; Research Funding relationship with Orchard Therapeutics; Research Funding relationship with PassageBio; Research Funding relationship with Travere Therapeutics; Research Funding relationship with Ultragenyx

 

Weitzel, Jeffrey, MD

Presenter

Speaker/Speaker's Bureau relationship with AstraZeneca

Williamson Dean, Lori, MS               

Presenter

Advisory Committee Member relationship with GeneDx

Yu, Timothy, MD, PhD

Presenter

Scientific Medical Advisor relationship with GeneTx Therapeutics; Scientific Medical Advisor relationship with Eisai G2D2; Scientific Medical Advisor relationship with Alnylam

 

The following moderators and presenters have nothing to disclose:

 

Abu-El-Haija, Aya, MD MPH

 

Akbar, Fizza, MS

 

Akkari, Yassmine, PhD

 

Alkuraya, Fowzan, MD, FACMG

 

Appelbaum, Paul, MD

 

Appelbaum, Paul, MD

 

Bailey, Diana, MS

 

Berg, Jonathan, MD/PhD

 

Berry, Gerard, MD

 

Bielas, Stephanie, PhD

 

Bien-Willner, Gabriel, PhD, MD

 

Bird, Lynne, MD

 

Bowling, Kevin, PhD

 

Bradley, David, MD

 

Buchanan, Adam, MS

 

Carey, David, PhD

 

Casanova, Jean-Laurent, MD, PhD

 

Chanprasert, Sirisak, MD

 

Chung, Brian Hon-Yin, MS, MD

 

Clayton, Ellen, MD, JD

Cusmano-Ozog, Kristina, MD

 

Cutting, Garry, MD

 

Davis, Erica, PhD

 

Dobin, Sheila, PhD

 

Dow, Margaret, MD

 

Ebbert, Mark, PhD

 

Edmondson, Andrew, MD/PhD

 

Elias, Ellen, MD

 

Elsea, Sarah, PhD, FACMG

 

Emrick, Lisa, MD

 

Eno, Celeste, PhD

 

Erwin, Angelika, MD, PhD

 

Evans, Rebecca, CGC

 

Fahrner, Jill, MD/PhD

 

Farooqi, Sadaf, PhD, FRCP, FMedSci

 

Fullerton, Stephanie, PhD

 

Gavrilova, Ralitza, MD

 

Geddes, Gabrielle, MD

 

Giordano, Jessica, MS

 

Glinton, Kevin, MD/PhD

Gray, Kathryn, MD/PhD

 

Goldstein, Alisa, PhD

Grochowsky, Angela, MD

 

Goldstein, Amy, MD

Gropman, Andrea, MD

 

Gupta, Punita, MD

Haldeman-Englert, Chad, MD

 

Hisama, Fuki, MD

 

Hodge, Jennelle, PhD

 

Hoenig, Megan MS

 

Hurst, Anna, MD, MS, FACMG

 

Jensik, Philip, PhD

Ji, Yuan, MS, PhD

 

Jobanputra, Vaidehi, PhD

 

Jones, Marilyn, MD

Kahn, Jeffrey, PhD, MPH

Kashmola-Perez, Iman, MS, LGC

 

Keppler-Noreuil, Kim, MD, FACMG

 

Khalek, Nahla, MD, MPH

 

King, Jennifer, MD

Kirmani, Salman, MBBS, FACMG

 

Klein, Christopher, MD

 

Koenig, Barbara, PhD

 

Krawitz, Peter, MD, PhD

 

Kraybill, Donald, PhD

 

Langlois, Sylvie, MD

 

Laukaitis, Christina, MD, PhD

Leung, Marco, PhD, FACMG

 

Marshall, Christian, PhD

 

Martin, Christa, PhD

 

Martinez-Agosto, Julian, MD. PhD

 

Matthews, Andrea, BS

 

McClure, Michelle, PhD

 

Might, Matthew, PhD

 

Miller, Jennifer, MD

 

Miller, Kristen Leppert, MGC, CGC

 

Moon-Grady, Anita, MD

 

Morava-Kozicz, Eva, MD, PhD

 

Morgan, Thomas, MD

 

Muthusamy, Karthik, MD

Nelson, Stanley, MD

 

Ngongang, Cedrik, MD

 

Niu, Zhiyv (Neal, PhD, FACMG

 

Oglesbee, Devin, PhD

 

Pagan, Jose, PhD

 

Pal, Tuya, MD

 

Pekarek, Dawn, MD

 

Perales Clemente, Ester, PhD

 

Pina-Aguilar, Raul, PhD, MD

 

Popejoy, Alice, PhD

 

Prakash, Siddharth, MD, PhD

 

Puffenberger, Erik, PhD

 

Quintero-Rivera, Fabiola, MD

 

Rahm, Alanna, PhD, LGC

 

Raraigh, Karen MS

 

Rasmussen, Sonja, MD, MS, FACMG

 

Rehm, Heidi, PhD, FACMG

 

Roberts, Jessica, JD

 

Rose, Sherrill, MD

 

Rotberg, Seth, MS

 

Russell, Bianca, MD

 

Sadikovic, Bekim, PhD

 

Samango-Sprouse, Carole, EdD

 

Schaaf, Christian, MD, PhD

 

Scheuner, Maren, MD, MS

 

Scott, Richard, MD, PhD

 

Seaver, Laurie, MD

 

Shaffer, Brian, MD, FACOG, FACMG

 

Shashi, Vandana, MD

 

Shieh, Joseph, MD, PhD

 

Shinawi, Marwan, MD

 

Slavotinek, Anne, MD, PhD

Soler-Alfonso, Claudia, MD

Slutsky, Emily, MD, MS

Stover, Samantha, CGC

 

Smith, Jessica, MD, FACMG, FACOG

Suskin, Barrie, MD

 

Sutherland, Nykole, MS

 

Tan, Khoon Ghee Queenie, MD, PhD

 

Tan, Wen-Hann, MD

 

Tatton-Brown, Katrina, MD

 

Terraf, Panieh, MSc, PhD

 

Tucci, Arianna, MD PhD

 

Vockley, Jerry, MD, PhD

 

Walton, Nephi, MD, MS

 

Wapner, Ronald, MD

 

Weck, Karen, MD, FCAP

 

Weksberg, Rosanna, MD, PhD

 

Williams, Eli, PhD

 

Wolff, Daynna, PhD

 

Yang, Chen, MD, PhD

 

Yap, Kai Lee, PhD


 

 

Accredited Sessions

Sessions

Laboratory Diagnostic Challenges (Constitutional and Neoplastic Cases in Molecular, Cytogenomic, and Biochemical Genetics Specialties)

Genomic Informatics on Clinical Service and Approaches to Evaluate the Unknown/Uncertain: An Interactive Workshop

Chromatinopathies: An Expanding Clinical Spectrum  

The Heart of the Matter - Congenital Cardiac Disease and Pregnancy

Heritable Human Genome Editing in Clinical Practice: Scientific, Social, Ethical, and Legal Perspectives   

Adult and Cancer Diagnostic Challenges

Excellence in Medical Genetics and Genomics Through Diversity

Telegenetics: Before, During and After COVID-19

Gene-Based Medicines to Treat Metabolic Disorders: Progress and Perspectives     

Hot Topics: Pushing the Boundaries of Genome Sequencing

Genetic Counselor Forum: In Utero Fetal Molecular Therapies: Present State and Future Applications

Pediatric Tumor Predisposition Syndromes: Update on Clinical Phenotypes, Associated Tumors, and Clinical Approaches to Surveillance

RNA and Gene Therapy in the Clinic – From Discovery to Treatment Implementation

Implementation of Whole Genome Sequencing as an Example of How to Bridge the Divide Between Research and Clinical Practice

Prenatal Diagnostic Challenges

Sex Chromosome Trisomies - To Screen or Not to Screen? - That is the Question

Bringing the New Era of Mitochondrial Genomic Medicine to Geneticists

Unexpected Findings Across the Lifespan: Challenges of Reporting Incidental and Secondary Findings in Young Patients   

A Primer on Regulatory and Compliance Agencies in Genetic Testing

Artificial Intelligence and Genomics – Powerful Tools in Pre- and Postnatal Decision Making

The Ehlers-Danlos Syndromes, Circa 2021: Clinical and Molecular Updates

What’s in a Panel? A Decade of Expanded Carrier Screening in Review

The Intersection Between Developmental Phenotypes and Perinatal Genomic Diagnoses   

Clinical Pharmacogenomic Testing: Current Best Practices and Future Landscape

Genetic Health Disparities: From Biology to Healthcare Delivery Systems

ACMG 2021 Cardinal Signs

R. Rodney Howell Symposium | Genetics in Medicine Presents: Spring 2021 COVID-19 State of the Science   

Plain People, Precision Medicine, and the Legacy of Victor McKusick

Power in Numbers: The Benefits of Rare Disease Consortia in Inborn Errors of Metabolism

Looking Beyond the Lamppost: Genome-First Approaches to Disease Prevalence, Penetrance, and Phenotype

The Evolution of Autopsy in the Era of Sequencing

Clinical, Legal, Ethical, and Economic Issues Surrounding Variant Reinterpretation

Diversity in Clinical Genetics Practices Around the World

Featured Platform Presentations

Platform Presentations- Cancer Genetics and Therapeutics

Platform Presentations -Genetic Counseling

Platform Presentations- Legal and Ethical Issues; Education

Platform Presentations- Clinical Genetics and Therapeutics

Platform Presentations- Public Health, Health Services and Implementation

Platform Presentations- Prenatal Genetics

Platform Presentations- Biochemical/Metabolic Genetics

Platform Presentations- Laboratory Genetics and Genomics

Summary
Availability: On-Demand
Expires on 07/01/2023
Cost : ACMG Member: $349.00
Non-Member: $399.00
Postdoc/Trainee (M): $349.00
Postdoc/Trainee (NM): $399.00
Student (M): $349.00
Student (NM): $399.00
Credit Offered:
62 CME (AMA) Credits
62 CME (Other) Credits
62 P.A.C.E. Credits
62 NSGC Credits
Contains: 3 Courses
Powered By